These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 17538362

  • 41. [Excessive growth and growth hormone deficiency after treatment for craniopharyngioma].
    López Siguero JP, García García E, Martínez-Aedo MJ, Martínez Valverde A.
    An Esp Pediatr; 2000 Jul; 53(1):64-6. PubMed ID: 10998409
    [Abstract] [Full Text] [Related]

  • 42. Endoscopy-assisted microsurgical total resection of craniopharyngioma in childhood.
    Kadri H, Mawla AA.
    Minim Invasive Neurosurg; 2006 Dec; 49(6):369-72. PubMed ID: 17323266
    [Abstract] [Full Text] [Related]

  • 43. Reversal of preoperative catatonic state by surgical resection of an adult-onset craniopharyngioma: case report and review of the literature.
    Massengale J, Tafti BA, Large L, Skirboll S.
    Cogn Behav Neurol; 2009 Mar; 22(1):67-71. PubMed ID: 19372773
    [Abstract] [Full Text] [Related]

  • 44. Unilateral hearing loss as primary symptom of craniopharyngioma in a six-year-old girl.
    Hofman R, Rosingh HJ.
    J Laryngol Otol; 2008 Mar; 122(3):e10. PubMed ID: 18252012
    [Abstract] [Full Text] [Related]

  • 45. [Pituitary apoplexy as the presenting symptom of a recurrent craniopharyngioma].
    Rangel-Castilla L, Ríos-Alanis M, Torres-Corzo J, Rodríguez-Della Vechia R, Chávez-López R.
    Rev Neurol; 2008 Mar; 39(3):297-8. PubMed ID: 15284969
    [No Abstract] [Full Text] [Related]

  • 46. [Tumor markers for diencephalon and pituitary diseases: urinary matrix metalloproteinases].
    Takano S.
    Nihon Rinsho; 2011 Mar; 69 Suppl 2():155-9. PubMed ID: 21830537
    [No Abstract] [Full Text] [Related]

  • 47. Recurrent depressive illness or craniopharyngioma: a diagnostic dilemma.
    Yusuf AJ, Mahmud MR, Ibinaiye PO, Liman AA.
    West Afr J Med; 2013 Mar; 32(2):153-5. PubMed ID: 23925990
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Craniopharyngioma.
    Wisoff JH.
    J Neurosurg Pediatr; 2008 Feb; 1(2):124-5; discussion 125. PubMed ID: 18352780
    [No Abstract] [Full Text] [Related]

  • 50. Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs.
    Moses MA, Harper J, Folkman J.
    N Engl J Med; 2006 Jun 15; 354(24):2621-2. PubMed ID: 16775248
    [No Abstract] [Full Text] [Related]

  • 51. Increased incidence of urinary matrix metalloproteinases as predictors of disease in pediatric patients with inflammatory bowel disease.
    Manfredi MA, Zurakowski D, Rufo PA, Walker TR, Fox VL, Moses MA.
    Inflamm Bowel Dis; 2008 Aug 15; 14(8):1091-6. PubMed ID: 18338781
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up.
    Muller HL.
    Horm Res; 2008 Aug 15; 69(4):193-202. PubMed ID: 18204266
    [Abstract] [Full Text] [Related]

  • 54. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
    Voland P, Besig S, Rad R, Braun T, Baur DM, Perren A, Langer R, Höfler H, Prinz C.
    Neuroendocrinology; 2009 Aug 15; 89(1):66-78. PubMed ID: 18708724
    [Abstract] [Full Text] [Related]

  • 55. Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
    Hegedüs L, Cho H, Xie X, Eliceiri GL.
    J Cell Physiol; 2008 Aug 15; 216(2):480-5. PubMed ID: 18286480
    [Abstract] [Full Text] [Related]

  • 56. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM, Carvalho AL, Pinto CA, Martins EP, Filho JG, Soares FA, Kowalski LP.
    Arch Otolaryngol Head Neck Surg; 2008 Jul 15; 134(7):743-9. PubMed ID: 18645125
    [Abstract] [Full Text] [Related]

  • 57. Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer.
    Mohammed MA, Seleim MF, Abdalla MS, Sharada HM, Abdel Wahab AH.
    BMC Urol; 2013 May 14; 13():25. PubMed ID: 23672427
    [Abstract] [Full Text] [Related]

  • 58. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C.
    Anticancer Drugs; 2008 Jul 14; 19(6):607-12. PubMed ID: 18525320
    [Abstract] [Full Text] [Related]

  • 59. Autopsy findings of a craniopharyngioma with a natural course over 60 years.
    Inenaga C, Kakita A, Iwasaki Y, Yamatani K, Takahashi H.
    Surg Neurol; 2004 Jun 14; 61(6):536-40; discussion 540. PubMed ID: 15165790
    [Abstract] [Full Text] [Related]

  • 60. Kerry's story: the challenges of facing a recurrent craniopharyngioma.
    Dusik-Sharpe J.
    Axone; 2004 Dec 14; 26(2):8-12. PubMed ID: 15663314
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.